Ketogenic Diet and Beta-Hydroxybutyrate in Colorectal Cancer
Authors:
- 1 December 2022
- journal article
- research article
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 41 (12) , 1007-1011
Abstract
Colorectal cancer (CRC) is one of the leading causes of cancer-related death in the United States. Although certain genetic predispositions may contribute to one's risk for developing CRC, dietary and lifestyle factors may play an important role as well. In a recent study in Nature, Dmitrieva-Posocco et al, reveal a potential protective role of the ketogenic diet in colorectal cancer growth and progression. Administration of a ketogenic diet to CRC-bearing mice demonstrated a tumor-suppressive effect. Specifically, the ketone body β-hydroxybutyrate (BHB) exhibited the ability to suppress epithelial cell proliferation and inhibit tumor growth. BHB acts on cancer cells through regulation of homeodomain-only protein Hopx, known regulator of CRC. Furthermore, BHB requires a surface receptor Hcar to induce Hopx expression and suppress proliferation of intestinal epithelial cells. Taken together, these results describe a new therapeutic approach of using dietary intervention for the prevention and treatment of colorectal cancer.Keywords
This publication has 41 references indexed in Scilit:
- The Homeobox Only Protein Homeobox (HOPX) and Colorectal CancerInternational Journal of Molecular Sciences, 2013
- Calcium, Magnesium, and Colorectal CancerEpidemiology, 2012
- Dietary Fiber Intake and Colorectal Cancer RiskTopics in Clinical Nutrition, 2011
- Aspirin for the prevention of colorectal cancerBest Practice & Research Clinical Gastroenterology, 2011
- Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trialsThe Lancet, 2010
- Association of adherence to lifestyle recommendations and risk of colorectal cancer: a prospective Danish cohort studyBMJ, 2010
- Convergence of Genetic, Nutritional and Inflammatory Factors in Gastrointestinal CancersNutrition Reviews, 2008
- Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2New England Journal of Medicine, 2007
- Folate: a magic bullet or a double edged sword for colorectal cancer prevention?Gut, 2006
- Molecular Evolution of the Histone Deacetylase Family: Functional Implications of Phylogenetic AnalysisJournal of Molecular Biology, 2004